Tag: biomedicine

Nyheter

CYTO365 and Velit Biologics on top at regional Venture Cup Väst final

2012-05-16 14:09 GöteborgBIO CYTO365 won the “Best business plan"-award, at the Venture Cup Väst (West) regional final held in Gothenburg on 10 May. The company has patented a safe new valve, “CYTO365", which prevents thrombosis and air embolism in patients during chemotherapy treatment.Velit Biologics, develops SB101, a new cancer drug which chokes tumours by cutting off their nutrients via blood vessels.

Diabetes drug can prevent heart disease

2012-03-16 14:29 GöteborgBIO The widely used diabetes medicine metformin can have protective effects on the heart, reveals a new study conducted at the Sahlgrenska Academy. Researchers at the University of Gothenburg's Sahlgrenska Academy have shown in a preliminary study in rats that one of the most common diabetes drugs, metformin, also has a protective effect on the heart.

Immunicum includes first patients in phase l/ll of cancer vaccine study

2012-03-12 09:27 GöteborgBIO Immunicum develops vaccines for the therapeutic treatment of cancer. The Gothenburg-based company now includes the first patients in phase l/ll of cancer vaccine study. In total, 12 patients with metastasis cancer of the kidney are being treated in order to investigate possible side effects and the antitumour effect of the vaccine.

Large study in Gothenburg could save a lot of hearts

2012-02-23 16:59 GöteborgBIO The biggest research study of heart, lung and blood diseases ever to have been carried out in Sweden - SCAPIS - Swedish Cardiopulmonary Bioimage Study - was recently initiated in Gothenburg. A number of regional medical and healthcare operators are going to try and identify individual risk factors for heart attacks, sudden cardiac arrests and other heart diseases.

2012-02-15 12:01 GöteborgBIO In June 2012, thirteen master students will have completed the first of their two years training at the Göteborg International Bioscience Business School, GIBBS. They are applying for internships/summer jobs in the biomedicine, healthcare and medtech industry.

Revolutionary approach to allergy prevention

2012-02-10 13:55 GöteborgBIO Premune is based on world-leading research in bacteriology and immunology, with 15 years of clinical studies at the University of Gothenburg and Sahlgrenska Academy. Serendipity Innovations AB has initiated an exciting collaboration with Encubator AB regarding the startup company Premune AB, a company that is expected to revolutionize the market with its new approach to allergy prevention.

Gothenburg stem cell researcher awarded grant from Hjärnfonden (Swedish Brain Foundation)

2012-01-23 15:53 GöteborgBIO Hjärnfonden collects donations and supports research about the whole brain and nervous system. Charlotta Lindwall, at the University of Gothenburg, receives SEK 280,000 for her research into stem cells.

Transplantation research moves to Sahlgrenska Science Park

2012-01-03 12:17 GöteborgBIO Transplantation related research is being organised in a completely new way within Transplantation Biology & Regenerative Medicine at the Transplantation Centre at Sahlgrenska University Hospital in Göteborg. The new concept is based on the purpose of transferring knowledge from research to patient as quickly as possible. The center now moves to Sahlgrenska Science Park offering ideal premises.

Life Science - one of five prioritized clusters in West Sweden

2011-12-19 13:40 GöteborgBIO "Five Clusters" is a collaboration between Chalmers University of Technology, The City of Gothenburg, University of Gothenburg, Region Västra Götaland and West Sweden Chamber of Commerce and describes five strong clusters in West Sweden that have been identified jointly by leading representatives from the academia and the public and private sector. Life Science in one of the clusters.

Award to Medfield Diagnostics

2011-11-18 11:55 GöteborgBIO Göteborg based Medfield Diagnostics is winner of National Instruments yearly "NI Graphical Systems Design Awards" in Sweden 2011. Medfield's first product, Strokefinder R10, is an instrument for researchers within stroke and neurological research and can be used both for snapshot measurements to differentiate between ischemic and hemorrhagic stroke as well as to monitor changes over time.